• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION CONTEGRA PULMONARY VALVED CONDUIT - SUPPORTED; CONDUIT,VALVED,PULMONIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION CONTEGRA PULMONARY VALVED CONDUIT - SUPPORTED; CONDUIT,VALVED,PULMONIC Back to Search Results
Model Number 200S
Device Problem Calcified (1077)
Patient Problems Aneurysm (1708); Endocarditis (1834); Pulmonary Valve Stenosis (2024); Pulmonary Valve Insufficiency/ Regurgitation (4452)
Event Date 01/01/2011
Event Type  Injury  
Manufacturer Narrative
Citation: dave, h.Et al.Risk factor analysis of 170 single-institutional contegra implantations in pulmonary position.Ann thorac surg 2011;91:195¿203.Doi: 10.1016/j.Athoracsur.2010.07.058.Earliest date of publish used for event date.Medtronic products referenced: contegra pulmonary valved conduit (pma# h020003, product code mwh).Earliest approved product used for product code and pma#.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding risk factor analysis of contegra implantations.All data were collected from a single center between 2001 and 2007.The study population included 170 patients (predominantly male, mean age 9 years), all of whom were implanted with medtronic contegra valved conduit.No serial numbers were provided.Among all contegra patients, adverse events included: stenosis, increased gradient measurements, severe regurgitation, calcification, outgrowth, aneurysm, endocarditis.Treatment included medication, balloon intervention or explant.Based on the available information a medtronic product may have been associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTEGRA PULMONARY VALVED CONDUIT - SUPPORTED
Type of Device
CONDUIT,VALVED,PULMONIC
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key11066996
MDR Text Key223458272
Report Number2025587-2020-03935
Device Sequence Number1
Product Code MWH
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
H020003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 12/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number200S
Device Catalogue Number200S
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/08/2020
Initial Date FDA Received12/23/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age9 YR
Patient Weight23
-
-